HeraMED (ASX:HMD) has raised US$2.8 million via placement and SPP
HeraMED Limited (ASX:HMD) has raised funds to accelerate HearCARE’s commercial roll out and progress ongoing research projects.
HeraMED is a medical technology company leading the digital transformation of maternity care with its proprietary telehealth platform. The company offers a platform that utilizes hardware and software to reshape the doctor/patient relationship using its clinically validated in-home fetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence, big data and a digital social networking dashboard.
Oaklins’ team in Australia acted as lead manager in this transaction.
相关交易
Xeros Technology Group has completed a placing, subscription and retail offer
Xeros Technology Group plc has raised funds to drive forward its commercialization strategy.
更多信息Infotreasury has been sold to Matera
Matera, a leading banking software company with world-class instant payments and core banking solutions, has acquired Infotreasury.
更多信息Fairness opinion provided to the independent Board members of Orange Belgium
The independent Board members of Orange Belgium have received a fairness opinion in the context of a contribution in-kind of VOO shares in Orange Belgium.
更多信息